William Burgin, MD
Vascular Neurology · Tampa, FLNPI 1508891524
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,330 of the $9,412 with a category attached, or 77.9%. Regeneron accounts for 68.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $6,702 and has fallen 98.2% since, to $121 in 2024.
Across 26 payments — averaging $362.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$6K
- Genentech, Inc.$2K
- Medtronic$566
- Viz.ai, Inc.$203
- CSL Behring$125
- Neurasignal Inc.$95
- plus $169 from 3 others
Across 15 payments — averaging $15,603 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$161K
- Sunovion Pharmaceuticals Inc.$73K
What the payments were for
- Consulting fees$7,33078%
- Travel & lodging$6287%
- Food & beverage$1,45415%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 11 | $6,455 |
| Genentech, Inc. | 1 | $1,800 |
| Medtronic(2 entities) | 5 | $566 |
| Viz.ai, Inc. | 3 | $203 |
| CSL Behring | 1 | $125 |
| Neurasignal Inc. | 1 | $95 |
| Chiesi USA, Inc. | 1 | $77 |
| Bayer | 2 | $57 |
| Amgen | 1 | $35 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRALUENT$6,262
- TNKase$1,800
- LINQ II$290
- Reveal LINQ$264
- Viz.AI LVO$141
- Kcentra$125
How this compares
$9,412 in reported general payments places this provider in the 75th percentile of 40 vascular neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular neurology in Tampa
- Maxim MokinTampa$137K
- John CasselTampa$10K
- Waldo GuerreroTampa$2K
- Robert MannelJacksonville Beach$92K
- Alexander SenetarSarasota$42K
- Amin AghaebrahimJacksonville$36K
- Miguel ChuquilinTallahassee$30K
- Richard CallisonFort Pierce$28K
- Farah FourcandVero Beach$11K
- Mehdi BouslamaFort Lauderdale$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.